Breaking News Instant updates and real-time market news.

2019-04-18 11:32:27 BBT Merged to become TFC $49.31 -0.51 (-1.02%) 11:32 04/18/19 04/18 11:32 04/18/19 11:32	BB&T confirms Fed termination of anti-money laundering related consent order BB&T Corporation announced the Board of Governors of the Federal Reserve System has terminated its Cease and Desist Order with BB&T Corporation related to BB&T's anti-money laundering program. No money laundering activity was identified and no financial penalty was levied in relation to this order, the bank stated. BB&T Chairman and CEO Kelly King said, "Since 2016, our highly experienced AML team has worked tirelessly to ensure our BSA/AML program meets and exceeds all required standards. Their efforts, along with our significant investments in technology and process improvements, have positioned us well for the future."	18 Apr 30 Apr 11 Jun
BBT Merged to become TFC $49.31 -0.51 (-1.02%) 03/26/19 03/26/19 UPGRADE Fly Intel: Top five analyst upgrades Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bed Bath & Beyond (BBBY) upgraded to Strong Buy from Market Perform at Raymond James , to Hold from Sell at Loop Capital, and to Sector Weight from Underweight at KeyBanc. 2. BB&T (BBT) upgraded to Buy from Hold at Deutsche Bank with analyst Matt O'Connor saying after meeting with CEO of SunTrust (STI), he remains positive on the merger and the combined stock. 3. Vertex (VRTX) upgraded to Outperform from Market Perform at William Blair with analyst Y. Katherine Xu citing expectations that the company's cystic fibrosis franchise will continue dominating after Proteostasis (PTI) reported disappointing triplet data. 4. Allegiant Travel (ALGT) upgraded to Outperform from Neutral at Macquarie with analyst Susan Donofrio citing her meetings with its management last week. 5. TransAlta (TAC) upgraded to Buy from Hold at TD Securities with analyst John Mould saying Brookfield Renewable Partners (BEP) $750M investment in TransAlta improves the company's financial flexibility, accelerates its ability to return capital to shareholders and advance the coal-to-gas conversion. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. 04/04/19 RAJA 04/04/19 DOWNGRADE RAJA Market Perform BB&T downgraded to Market Perform from Outperform at Raymond James 04/04/19 04/04/19 UPGRADE Target $44 Strong Buy Synovus upgraded to Strong Buy at Raymond James As previously reported, Raymond James analyst David Lon upgraded Synovus (SNV) to Strong Buy from Outperform, with a $44 price target. The analyst cited the recent pullback in the stock and what he sees as an outsized opportunity for market share gain stemming from the recently announced BB&T (BBT)-SunTrust (STI) mega merger. 04/04/19 RAJA 04/04/19 DOWNGRADE RAJA Market Perform BB&T downgraded to Market Perform on near-term noise at Raymond James As previously reported, Raymond James analyst David Lon downgraded BB&T (BBT) to Market Perform from Outperform and reducing his EPS estimates. The analyst cited the nearer-term noise surrounding its merger with SunTrust (STI) and his view that BB&T shares are unlikely to outperform until there is greater clarity on when the deal will actually close and its ability to retain key talent with the combined company's footprint. Moreover, larger acquirer stock prices generally haven't reacted favorably over the past few years, he contends.

2019-04-18 11:32:27

BBT

Merged to become TFC

$49.31: -0.51 (-1.02%)

11:32

04/18/19

04/18

11:32

04/18/19

11:32

BB&T confirms Fed termination of anti-money laundering related consent order

BB&T Corporation announced the Board of Governors of the Federal Reserve System has terminated its Cease and Desist Order with BB&T Corporation related to BB&T's anti-money laundering program. No money laundering activity was identified and no financial penalty was levied in relation to this order, the bank stated. BB&T Chairman and CEO Kelly King said, "Since 2016, our highly experienced AML team has worked tirelessly to ensure our BSA/AML program meets and exceeds all required standards. Their efforts, along with our significant investments in technology and process improvements, have positioned us well for the future."

18
Apr
30
Apr
11
Jun

BBT Merged to become TFC

$49.31: -0.51 (-1.02%)

03/26/19

04/04/19: RAJA

04/04/19

04/04/19: RAJA

TODAY'S FREE FLY STORIES

LULU Lululemon $233.31 3.75 (1.63%) 06:09 12/12/19 12/12 06:09 12/12/19 06:09 Recommendations	Lululemon analyst commentary » Lululemon Q3 beat shows… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
INTC Intel $57.04 0.43 (0.76%) , IBM IBM $133.81 -0.12 (-0.09%) 06:09 12/12/19 12/12 06:09 12/12/19 06:09 Periodicals	Intel hires former GlobalFoundries CTO Gary Patton, Reuters reports » Intel (INTC) has hired… INTC Intel $57.04 0.43 (0.76%) IBM IBM $133.81 -0.12 (-0.09%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Jan
HD Home Depot $211.96 -3.88 (-1.80%) 06:06 12/12/19 12/12 06:06 12/12/19 06:06 Downgrade	Home Depot rating change » Home Depot downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb
JPM JPMorgan $134.17 -0.31 (-0.23%) 06:06 12/12/19 12/12 06:06 12/12/19 06:06 Periodicals	JPMorgan to revamp wealth management business, WSJ reports » JPMorgan is combining its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	14 Jan
WST West Pharmaceutical $146.54 1.07 (0.74%) 06:06 12/12/19 12/12 06:06 12/12/19 06:06 Downgrade	West Pharmaceutical rating change » West Pharmaceutical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

CHEF Chefs' Warehouse $35.51 -0.06 (-0.17%) 06:05 12/12/19 12/12 06:05 12/12/19 06:05 Initiation	Chefs' Warehouse initiated » Piper Jaffray starts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec
OII Oceaneering $13.48 0.32 (2.43%) 06:03 12/12/19 12/12 06:03 12/12/19 06:03 Upgrade	Oceaneering rating change » Oceaneering upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SYY Sysco $82.88 0.38 (0.46%) 06:03 12/12/19 12/12 06:03 12/12/19 06:03 Initiation	Sysco initiated » Sysco initiated with an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MPWR Monolithic Power $169.05 4.15 (2.52%) 06:01 12/12/19 12/12 06:01 12/12/19 06:01 Initiation	Monolithic Power initiated » Rosenblatt starts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HD Home Depot $211.96 -3.88 (-1.80%) 06:01 12/12/19 12/12 06:01 12/12/19 06:01 Upgrade	Home Depot rating change » Home Depot upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb

SPNE SeaSpine $12.00 -0.58 (-4.61%) 05:57 12/12/19 12/12 05:57 12/12/19 05:57 Downgrade	SeaSpine rating change » SeaSpine downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GMED Globus Medical $56.88 0.03 (0.05%) 05:56 12/12/19 12/12 05:56 12/12/19 05:56 Upgrade	Globus Medical rating change » Globus Medical upgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GKOS Glaukos $57.32 -1.895 (-3.20%) 05:56 12/12/19 12/12 05:56 12/12/19 05:56 Downgrade	Glaukos rating change » Glaukos downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MMSI Merit Medical $29.99 0.69 (2.35%) 05:55 12/12/19 12/12 05:55 12/12/19 05:55 Downgrade	Merit Medical rating change » Merit Medical downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SWAV ShockWave Medical $41.84 1.41 (3.49%) 05:55 12/12/19 12/12 05:55 12/12/19 05:55 Upgrade	ShockWave Medical rating change » ShockWave Medical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

DPZ Domino's Pizza $293.12 8.48 (2.98%) , PZZA Papa John's $60.84 1.29 (2.17%) … 05:55 12/12/19 12/12 05:55 12/12/19 05:55 Conference/Events	Stephens to hold a plane trip » Restaurants Plane Trip… DPZ Domino's Pizza $293.12 8.48 (2.98%) PZZA Papa John's $60.84 1.29 (2.17%) TXRH Texas Roadhouse $57.25 0.55 (0.97%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 13 Dec 18 Dec
MPWR Monolithic Power $169.05 4.15 (2.52%) 05:47 12/12/19 12/12 05:47 12/12/19 05:47 Initiation	Monolithic Power initiated » Monolithic Power… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HUYA Huya $18.21 0.6 (3.41%) 05:35 12/12/19 12/12 05:35 12/12/19 05:35 Initiation	Huya initiated » Huya initiated with a Buy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GMAB Genmab , AZN AstraZeneca $48.19 0.23 (0.48%) … 05:32 12/12/19 12/12 05:32 12/12/19 05:32 Downgrade	Genmab, AstraZeneca, Roche rating change » Genmab downgraded to Hold… GMAB Genmab AZN AstraZeneca $48.19 0.23 (0.48%) RHHBY Roche $0.00 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 16 Dec 17 Dec
WBA Walgreens Boots Alliance $58.00 -0.4 (-0.68%) , MCK McKesson $143.40 0.59 (0.41%) 05:31 12/12/19 12/12 05:31 12/12/19 05:31 Hot Stocks	Walgreens Boots Alliance, McKesson create German wholesale JV » Walgreens Boots Alliance… WBA Walgreens Boots Alliance $58.00 -0.4 (-0.68%) MCK McKesson $143.40 0.59 (0.41%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	08 Jan

MTUAY MTU Aero Engines $0.00 (0.00%) 05:30 12/12/19 12/12 05:30 12/12/19 05:30 Downgrade	MTU Aero Engines rating change » MTU Aero Engines… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
RHHBY Roche $0.00 (0.00%) , HALO Halozyme $18.74 -0.46 (-2.40%) 05:30 12/12/19 12/12 05:30 12/12/19 05:30 Hot Stocks	Genentech says Phase III FeDeriCa study met primary endpoint » Genentech, a member of… RHHBY Roche $0.00 (0.00%) HALO Halozyme $18.74 -0.46 (-2.40%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	12 Dec 16 Dec
OEZVY Verbund $0.00 (0.00%) 05:28 12/12/19 12/12 05:28 12/12/19 05:28 Upgrade	Verbund rating change » Verbund upgraded to Buy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ALV Autoliv $83.17 0.81 (0.98%) 05:25 12/12/19 12/12 05:25 12/12/19 05:25 Upgrade	Autoliv rating change » Autoliv upgraded to Buy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	17 Dec
AMGN Amgen $233.96 0.14 (0.06%) 05:25 12/12/19 12/12 05:25 12/12/19 05:25 Hot Stocks	Amgen, UCB announce EC approval of EVENITY » Amgen and UCB announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

PT
Today at 07:00

Pintec Technology - PT Conference Calls
VERU
Today at 08:00

Veru - VERU Conference Calls
MET
Today at 08:00

MetLife, Inc. Firm Sponsored Meetings

, New York, NY
Today at 08:30

PPI-FD less food, energy & trade services - Y/Y: November 2019 Government Event
Today at 08:30

Producer Price Index M/M: November 2019 Government Event
Today at 08:30

6-Month Bill Announcement Government Event
Today at 08:30

Producer Price Index Y/Y: November 2019 Government Event
Today at 08:30

PPI-FD less food & energy - M/M: November 2019 Government Event
Today at 08:30

New Jobless Claims Level: Week 12/7 Government Event
Today at 08:30

PPI-FD less food & energy - Y/Y: November 2019 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CRWD X CRWD Crowdstrike Block Trade Managers: Goldman Sachs Priced at: $49.40 2.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AUPH X AUPH Aurinia Pharmaceuticals Secondary Managers: Jefferies & SVB Leerink, H.C. Wainwright, Oppenheimer, Bloom Burton Priced at: $15.00 11.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XAIR X XAIR Beyond Air Secondary Managers: SunTrust, National Securities, Roth Capital, Laidlaw Priced at: $3.66 2.325M Shares ABR X ABR Arbor Realty Spot Secondary Managers: JPMorgan, JMP Securities & Raymond James Priced at: $14.14 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CFRX X CFRX ContraFect Spot Secondary Managers: Maxim Priced at: $.27 37.15M Shares RHP X RHP Ryman Hospitality Spot Secondary Managers: BofA/Merrill, JPMorgan & Wells Fargo Priced at: $85.60 3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SCYX X SCYX Scynexis Spot Secondary Managers: H.C. Wainwright Priced at: $.90 38.89M Shares
Tues	XP X XP XP IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley, XP & Itau BBA, BofA/Merrill, Citi, Credit Suisse, UBS Priced at: $27.00 72.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNST X CNST Constellation Pharmaceuticals Spot Secondary Managers: JPMorgan, Jefferies & Cowen, RBC Capital, SunTrust Priced at: $34.50 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GMRE X GMRE Global Medical REIT Spot Secondary Managers: Stifel, BMO Capital, Baird, KeyBanc & SunTrust Priced at: $13.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Jaffray & Stifel, BTIG, JMP Securities, SunTrust Priced at: $36.50 1.57M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDGL X MDGL Madrigal Pharmaceuticals Spot Secondary Managers: Goldman Sachs Priced at: $107.85 1.2M Shares MRNS X MRNS Marinus Pharmaceuticals Spot Secondary Managers: Oppenheimer & Ladenburg Priced at: $1.25 28M Shares PACK X PACK Ranpak Holdings Spot Secondary Managers: Craig-Hallum Priced at: $6.50 15.384M Shares PMT X PMT PennyMac Mortgage Spot Secondary Managers: Morgan Stanley, Credit Suisse, BofA/Merrill, JPMorgan & Barclays, Nomura Instinet, Piper Jaffray Priced at: $22.10 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCKT X RCKT Rocket Pharmaceuticals Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LifeSci Priced at: $22.25 3.82M Shares
Wed	BILL X BILL Bill.com IPO Managers: Goldman Sachs, BofA/Merrill, Jefferies & KeyBanc, Canaccord, Needham, William Blair Priced at: $22.00 9.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LVGO X LVGO Livongo Health Secondary Managers: Morgan Stanley, Goldman Sachs & JPMorgan Priced at: $27.00 2.78M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MNRL X MNRL Brigham Minerals Secondary Managers: Credit Suisse, Goldman Sachs & RBC Capital Priced at: $18.10 11M Shares FTSV X FTSV Forty Seven Spot Secondary Managers: Morgan Stanley & Credit Suisse Priced at: $35.00 4.86M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EH X EH Ehang IPO Managers: Morgan Stanley, Needham, Tigress Financial, Prime Number $12.50-14.50 3.2M Shares MNTA X MNTA Momenta Secondary Managers: Goldman Sachs & JPMorgan, Stifel $18.07 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASMB X ASMB Assembly Biosciences Spot Secondary Managers: Jefferies & SVB Leerink $17.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	OCFT X OCFT OneConnect IPO Managers: Morgan Stanley, Goldman Sachs, JPMorgan & Ping An of China, BofA/Merrill, HSBC, CLSA, KeyBanc $9.00-10.00 26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SPT X SPT Sprout Social IPO Managers: Goldman Sachs, Morgan Stanley, KeyBanc & William Blair, Canaccord, Stifel $16.00-18.00 8.824M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AQST X AQST Aquestive Therapeutics Secondary Managers: BMO Capital $7.51 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PHR X PHR Phreesia Secondary Managers: JPMorgan, Wells Fargo, William Blair, Allen & Co., Piper Jaffray, Baird, Raymond James $28.72 6M Shares
Fri	No deals

View All Syndicate Announcements »

BB&T confirms Fed termination of anti-money laundering related consent order

TODAY'S FREE FLY STORIES

Get Full Fly Access